Prospective Clinical Trial of 177Lu-P17-088 in the Treatment of Metastatic Castration-Resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Conditions

Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China
Contact: Study coordinator (Guochang Wang, MD) · guochang1007@163.com · +86-0591 87981619
Contact: Study coordinator (Jie Zang, MD) · 15901495106@163.com · +86-0591 87981619

Study leads

Weibing Miao, MD
Study Chair
Department of Nuclear Medicine, First Affiliated Hospital of Fujian Medical University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI

Prostate Cancer Patients Treated by Radiotherapy

Abroad (travel likely)RecruitingPHASE2

Cairo, Egypt · Shibīn al Kawm, Egypt

A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate Cancer

Metastatic Castration-resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Phoenix, United States · Tucson, United States

A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Metastatic Castration-Resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE2

Goodyear, United States · Scottsdale, United States

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Prostate Cancer · Localized Prostate Carcinoma

Abroad (travel likely)RecruitingPHASE2

Miami, United States